<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16012">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02898428</url>
  </required_header>
  <id_info>
    <org_study_id>SDC-2016-055</org_study_id>
    <nct_id>NCT02898428</nct_id>
  </id_info>
  <brief_title>Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes</brief_title>
  <official_title>Continuous Glucose Monitoring During Breastfeeding or Formula Feeding in New Mothers With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steno Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Steno Diabetes Center</source>
  <brief_summary>
    <textblock>
      With appropriate day-time carbohydrate intake and insulin dose, the 24 hour glucose levels
      and prevalence of night-time hypoglycaemia are comparable in breastfeeding new mothers and
      formula feeding new mothers with type 1 diabetes at the second after delivery diabetes
      control compared with the first after delivery diabetes control at Steno Diabetes Center.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hypoglycemia</measure>
    <time_frame>Night-time 8 hours</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypoglycemia</condition>
  <condition>Breastfeeding</condition>
  <arm_group>
    <arm_group_label>New mothers</arm_group_label>
    <description>New mothers with type 1 diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Non-pregnant, non-breastfeeding women with type 1 diabetes matched for age and BMI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous glucose monitoring (CGM)</intervention_name>
    <arm_group_label>New mothers</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        New mothers with type 1 diabetes
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 45 years.

          -  Delivery of a single infant.

          -  Proficiency in Danish to read and understand the patient information sheet,
             questionnaires and to converse with the diabetes caregivers.

        Exclusion Criteria:

          -  A diagnosis with severe mental or psychiatric barriers or a concurrent disease on the
             decision of the principal investigator
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Steno Diabetes Center</name>
      <address>
        <city>Gentofte</city>
        <zip>2820</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lene Ringholm, MD, PhD</last_name>
      <phone>+45 30797036</phone>
      <email>enel@dadlnet.dk</email>
    </contact>
    <contact_backup>
      <last_name>Henrik U Andersen, DMsC</last_name>
      <phone>+45 44421438</phone>
      <email>hua@steno.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 12, 2016</lastchanged_date>
  <firstreceived_date>September 8, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Steno Diabetes Center</investigator_affiliation>
    <investigator_full_name>Lene Ringholm</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
